181 related articles for article (PubMed ID: 37639602)
41. Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.
Yamin G; Teplow DB
J Neurochem; 2017 Jan; 140(2):210-215. PubMed ID: 27943341
[TBL] [Abstract][Full Text] [Related]
42. Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.
Gouwens LK; Makoni NJ; Rogers VA; Nichols MR
Brain Res; 2016 Oct; 1648(Pt A):485-495. PubMed ID: 27531183
[TBL] [Abstract][Full Text] [Related]
43. Protofibrillar and Fibrillar Amyloid-β Binding Proteins in Cerebrospinal Fluid.
Rahman MM; Westermark GT; Zetterberg H; Härd T; Sandgren M
J Alzheimers Dis; 2018; 66(3):1053-1064. PubMed ID: 30372682
[TBL] [Abstract][Full Text] [Related]
44. Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular modelling approach.
Mohammed AA; Barale SS; Kamble SA; Paymal SB; Sonawane KD
Int J Biol Macromol; 2023 Jul; 242(Pt 3):124880. PubMed ID: 37217059
[TBL] [Abstract][Full Text] [Related]
45. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H; Sehlin D; Johansson AS; Nilsson LN; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
J Neurochem; 2007 Oct; 103(1):334-45. PubMed ID: 17623042
[TBL] [Abstract][Full Text] [Related]
46. Lecanemab in Early Alzheimer's Disease.
van Dyck CH; Swanson CJ; Aisen P; Bateman RJ; Chen C; Gee M; Kanekiyo M; Li D; Reyderman L; Cohen S; Froelich L; Katayama S; Sabbagh M; Vellas B; Watson D; Dhadda S; Irizarry M; Kramer LD; Iwatsubo T
N Engl J Med; 2023 Jan; 388(1):9-21. PubMed ID: 36449413
[TBL] [Abstract][Full Text] [Related]
47. Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states.
Algamal M; Ahmed R; Jafari N; Ahsan B; Ortega J; Melacini G
J Biol Chem; 2017 Oct; 292(42):17158-17168. PubMed ID: 28798235
[TBL] [Abstract][Full Text] [Related]
48. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
[TBL] [Abstract][Full Text] [Related]
49. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
[TBL] [Abstract][Full Text] [Related]
50. Peptides as Potential Therapeutics for Alzheimer's Disease.
Ribarič S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385735
[TBL] [Abstract][Full Text] [Related]
51. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
52. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
[TBL] [Abstract][Full Text] [Related]
53. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Thal DR; Walter J; Saido TC; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
[TBL] [Abstract][Full Text] [Related]
54. Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury.
Abu Hamdeh S; Waara ER; Möller C; Söderberg L; Basun H; Alafuzoff I; Hillered L; Lannfelt L; Ingelsson M; Marklund N
Brain Pathol; 2018 Jul; 28(4):451-462. PubMed ID: 28557010
[TBL] [Abstract][Full Text] [Related]
55. Alzheimer's disease as oligomeropathy.
Ono K
Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
[TBL] [Abstract][Full Text] [Related]
56. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.
Martin TD; Malagodi AJ; Chi EY; Evans DG
J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122
[TBL] [Abstract][Full Text] [Related]
57. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.
Tolar M; Abushakra S; Hey JA; Porsteinsson A; Sabbagh M
Alzheimers Res Ther; 2020 Aug; 12(1):95. PubMed ID: 32787971
[TBL] [Abstract][Full Text] [Related]
58. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
Singh K; Kaur A; Goyal D; Goyal B
Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
[TBL] [Abstract][Full Text] [Related]
59. Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer's Disease.
Kozin SA; Kechko OI; Adzhubei AA; Makarov AA; Mitkevich VA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203242
[TBL] [Abstract][Full Text] [Related]
60. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
Shuaib S; Narang SS; Goyal D; Goyal B
J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
